Fact CheckerSign in

NCT05168046Completed

Mindfulness-based Intervention for People With Parkinsonian Tremor

Pilot Study of the Ambulatory Monitoring Evaluation of a Mindfulness Meditation Programme in Parkinsonian Tremor

Source: ClinicalTrials.gov · Last updated 30 Sept 2025

Brief summary (registry, in English)

Mindfulness meditation is an approach that has shown interest in treatment of anxiety in Parkinson's disease. This pilot study aims to assess a more specific effect on tremor using Essential Tremor Embarrassment Assessment and inertial sensors allowing monitoring during sessions and in daily life. This study will focus on 20 patients (10 with and without Mindfulness based intervention and will aim to develop the interface and demonstrate proof of concept before setting up a controlled study

Status (registry)
Completed
Study type
Interventional
Enrollment
21 (actual)
First submitted
29 Oct 2021
Start date
15 Nov 2021
Primary completion date
20 Oct 2024
Lead sponsor
University Hospital, Montpellier
NCT number
NCT05168046

What you commit to

  • Study type: Interventional
  • Participants enrolled: 21
  • From 15 Nov 2021 to the primary completion date, 20 Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Psychotic disorders - Confusional syndrome
  • presence of signs in favor of an atypical parkinsonian syndrome (oculomotor impairment, early falls, hallucinations, MoCA \<20, early dysautonomia)

Other

  • Presence of disturbing dyskinetic movements (Item MDS-UPDRS4.2\> 1)
  • Patient who has already practiced meditation in the last 5 years
  • Untreated major depressive episode
  • Hallucinations (Item MDS-UPDRS1.2\> 1))
  • adult protected by law (guardianship, curatorship or under legal protection)
    • deprivation of liberty by judicial or administrative decision
    • high probability of non-compliance with the protocol or abandonment during the study
  • refusal to sign informed consent
  • Pregnant or breastfeeding woman
  • Lack of social coverage.

Who the study is looking for

  • Parkinson disease
  • Hoehn st and yahr stage \<or = 3
  • Age between 35 and 85 years old
  • Treatment stabilized for at least 3 months
  • Disturbing parkinsonian tremor of the upper limb (item MDS -UPDRS 2.10\> 1) and lasting 2 to 6 hours per day
  • patients with internet access

Age in the registry: 35 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Montpellier University Hospital
Coordinator of this site? Confirm its status
MontpellierFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.